Pharmatest has received the renewal of its French Tax Credit approval for the years 2021, 2022, 2023. The French Tax Credit Incentive (Crédit d’Impôt Recherche CIR) is a tax relief measure for companies focused on Research & Development activities for organizations based in France. The CIR is designed for all companies subject to corporate or income tax, regardless of their size or sector.
The incentive is applicable to Research & Development studies or projects outsourced to approved third parties, such as Pharmatest. We can assist you in your R&D project and provide you with a tax reduction of up to 30%.
The basis for eligibility is investment in research and development within the European Economic Area. Qualified expanses are for example outsourced R&D expenses (by approved organizations), technical staff costs, operating expenses, depreciation costs, patent filing.
For more information on CIR benefits and filing, please visit the Ministry of Higher Education, Research and Innovation website.